Loss of SNX6 resulted in the downregulation of N-cadherin and ZEB1, a mesenchymal gene and transcriptional factor, respectively, whereas upregulating E-cadherin resulted in the inhibition of the migration and invasive capacity of the cancer cells. The gene discussed is SNX6; the disease is cancer.